Home > Financial Ratios > SMS PHARMACEUTICALS

SMS PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
SMS PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SMS PHARMACEUTICALS
Please provide your vote to see the results

SMS PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 19.80103.90-50.38-3.8346.34

What is the latest Core EBITDA Growth ratio of SMS PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of SMS PHARMACEUTICALS is 19.80 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202519.80
Mar2024103.90
Mar2023-50.38
Mar2022-3.83
Mar202146.34

How is Core EBITDA Growth of SMS PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 19.8
-80.94
Mar2024 103.9
Positive
Mar2023 -50.38
Negative
Mar2022 -3.83
Negative
Mar2021 46.34 -

Other Financial Ratios of SMS PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of SMS PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SMS PHARMACEUTICALS ₹3,161.4 Cr -0.6% 5.5% 48% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,019.0 Cr -3% -3.6% -4.9% Stock Analytics
DIVIS LABORATORIES ₹168,752.0 Cr -3.1% 0.1% 11.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,542.0 Cr -3.7% 4% 18.8% Stock Analytics
CIPLA ₹115,883.0 Cr -1.3% -4.6% -1.5% Stock Analytics
DR REDDYS LABORATORIES ₹99,024.7 Cr -4.2% -7% -11.4% Stock Analytics


SMS PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SMS PHARMACEUTICALS

-0.6%

5.5%

48%

SENSEX

-1.9%

-2.2%

7.4%


You may also like the below Video Courses